116 related articles for article (PubMed ID: 38333933)
1. The role of gastrin 17 and pepsinogen I:pepsinogen II ratio in pathological diagnosis and endoscopic selection in gastritis patients.
Ye Q; Xu K; Tong Y; Zhao M
Lab Med; 2024 Feb; ():. PubMed ID: 38333933
[TBL] [Abstract][Full Text] [Related]
2. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
3. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
Haj-Sheykholeslami A; Rakhshani N; Amirzargar A; Rafiee R; Shahidi SM; Nikbin B; Khosravi F; Massarrat S
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):174-9. PubMed ID: 18237867
[TBL] [Abstract][Full Text] [Related]
4. Analysis of gastrin-17 and its related influencing factors in physical examination results.
Zeng J; Shen Y; Xu S; Yang R
Immun Inflamm Dis; 2023 Oct; 11(10):e993. PubMed ID: 37904688
[TBL] [Abstract][Full Text] [Related]
5. [Pepsinogen and gastrin in the noninvasive diagnosis of gastric atrophy. A case-control study in Peruvian population].
Colarossi A; Inga R; Prochazka R; Reyes U; Bussalleu A; BarĂșa RL
Rev Gastroenterol Peru; 2011; 31(2):110-5. PubMed ID: 21836650
[TBL] [Abstract][Full Text] [Related]
6. Basal and stimulated gastrin and pepsinogen levels after eradication of Helicobacter pylori: a 1-year follow-up study.
Gisbert JP; Boixeda D; Al-Mostafa A; Vila T; de Rafael L; Alvarez Baleriola I; de Argila CM; Abraira V
Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):189-200. PubMed ID: 10102232
[TBL] [Abstract][Full Text] [Related]
7. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of atrophic body gastritis in Chinese patients by measuring serum pepsinogen.
Wu KC; Li HT; Qiao TD; Li CN; Ji WS; Tian FQ; Wang X; Wang BL; Miao JY; Ding J; Fan DM
Chin J Dig Dis; 2004; 5(1):22-7. PubMed ID: 15612668
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in northern Iran.
Nejadi-Kelarijani F; Roshandel G; Semnani S; Ahmadi A; Faghani B; Besharat S; Akhavan-Tabib A; Amiriani T
Asian Pac J Cancer Prev; 2014; 15(17):7433-6. PubMed ID: 25227854
[TBL] [Abstract][Full Text] [Related]
10. The Diagnostic Value of Serum Gastrin-17 and Pepsinogen for Gastric Cancer Screening in Eastern China.
Shen H; Xiong K; Wu X; Cheng S; Lou Q; Jin H; Zhang X
Gastroenterol Res Pract; 2021; 2021():6894248. PubMed ID: 33936196
[TBL] [Abstract][Full Text] [Related]
11. Association between abnormal gastric function risk and Helicobacter pylori infection assessed by ELISA and 14C-urea breath test.
Gong Y; Wei W; Yuan Y
Diagn Microbiol Infect Dis; 2014 Dec; 80(4):316-20. PubMed ID: 25284372
[TBL] [Abstract][Full Text] [Related]
12. Serum gastrin-17 concentration for prediction of upper gastrointestinal tract bleeding risk among peptic ulcer patients.
Wang JX; Cao YP; Su P; He W; Li XP; Zhu YM
World J Clin Cases; 2021 Dec; 9(35):10948-10955. PubMed ID: 35047605
[TBL] [Abstract][Full Text] [Related]
13. HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE.
Coelho MCF; Ribeiro HG; Gomes CGO; Marinho FP; Barbosa AJA; Coelho LGV
Arq Gastroenterol; 2021; 58(1):39-47. PubMed ID: 33909795
[TBL] [Abstract][Full Text] [Related]
14. Relationship among serum pepsinogens, serum gastrin, gastric mucosal histology and H. pylori virulence factors in a paediatric population.
Lopes AI; Palha A; Lopes T; Monteiro L; Oleastro M; Fernandes A
Scand J Gastroenterol; 2006 May; 41(5):524-31. PubMed ID: 16638693
[TBL] [Abstract][Full Text] [Related]
15. [Clinical utility of serum pepsinogen levels as a screening test of atrophic gastritis].
Chae H; Lee JH; Lim J; Kim M; Kim Y; Han K; Kang CS; Shim SI; Kim JI; Park SH
Korean J Lab Med; 2008 Jun; 28(3):201-6. PubMed ID: 18594172
[TBL] [Abstract][Full Text] [Related]
16. The value of detecting pepsinogen and gastrin-17 levels in serum for pre-cancerous lesion screening in gastric cancer.
Yu G; Wang GX; Wang HG; Mo FF; Tang BB
Neoplasma; 2019 Jul; 66(4):637-640. PubMed ID: 31058531
[TBL] [Abstract][Full Text] [Related]
17. Value of Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and
Sivandzadeh GR; Zadeh Fard SA; Zahmatkesh A; Anbardar MH; Lankarani KB
Middle East J Dig Dis; 2023 Jan; 15(1):37-44. PubMed ID: 37547155
[No Abstract] [Full Text] [Related]
18. Associations of Serum Pepsinogens and Helicobacter Pylori Infection with High-Sensitivity C-Reactive Protein in Medical Examination Population.
Liu H; Fei C; Zhang J
Lab Med; 2021 Jan; 52(1):57-63. PubMed ID: 32702129
[TBL] [Abstract][Full Text] [Related]
19. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels.
Kiyohira K; Yoshihara M; Ito M; Haruma K; Tanaka S; Chayama K
J Gastroenterol; 2003; 38(4):332-8. PubMed ID: 12743772
[TBL] [Abstract][Full Text] [Related]
20. Serum anti-Helicobacter pylori immunoglobulin G titer correlates with grade of histological gastritis, mucosal bacterial density, and levels of serum biomarkers.
Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Yuan Y
Scand J Gastroenterol; 2014 Mar; 49(3):259-66. PubMed ID: 24329006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]